Monoclonal Antibody for Asthma and COPD Market Towards USD 58.94 Billion by 2035
Monoclonal Antibody for Asthma and COPD Market Towards USD 58.94 Billion by 2035 The global monoclonal antibody for asthma and COPD market size was valued at USD 34.02 billion in 2025 and is predicted to hit around USD 58.94 billion by 2035, rising at a 5.65% CAGR, a study published by Towards Healthcare a sister […]